Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: A case-control study

AIDS Research and Therapy

Volumn 8, Issue , 2011, Pages

  Abaynew, Yeshewas ^a   Deribew, Amare ^b   Deribe, Kebede ^c  

^a Dessie Health Science College   (Ethiopia)

^b JIMMA UNIVERSITY   (Ethiopia)

^c American Refuge Committee International ^*  (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVERSE DRUG REACTION; AIDS PATIENT; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; ATTITUDE TO AIDS; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE SEVERITY; ETHIOPIA; FEMALE; HELP SEEKING BEHAVIOR; HOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; STIGMA; STRUCTURED INTERVIEW;

EID: 79952052897     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-8-8     Document Type: Article

References (21)

1. UNAIDS UNAIDS Report on the global AIDS epidemic. 2010, Available online accessed 04/02/2011, UNAIDS., http://www.unaids.org/documents/20101123_GlobalReport_Annexes1_em.pdf
2. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002, 360:119-129. 10.1016/S0140-6736(02)09411-4, 12126821.
3. Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS 2001, 15:2251-57. 10.1097/00002030-200111230-00006, 11698698.
4. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. Aids 2002, 16:1945-1951. 10.1097/00002030-200209270-00012, 12351955.
5. Sterling TRCR, Keruly J, Moore RD. Improved Outcomes with Earlier Initiation of Highly Active Antiretroviral Therapy Among Human Immunodeficiency VirusInfected Patients Who Achieve Durable Virologic Suppression: Longer Follow-Up of an Observational Cohort Study. J Infect Dis 2003, 188:1659-1665. 10.1086/379741, 14639536.
6. Chadborn TR, Baster K, Delpech VC, Sabin CA, Sinka K, Rice BD, Evans BG. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). Aids 2005, 19:513-520. 10.1097/01.aids.0000162340.43310.08, 15764857.
7. Posse M, Meheus F, van Asten H, et al. Barriers to access to antiretroviral treatment in developing countries: a review. Tropical Medicine and International Health 2008, 13(7):904-913. 10.1111/j.1365-3156.2008.02091.x, 18466183.
8. Kigoz LM, Dobkin LM, Martin JN, et al. Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa. Journal of Acquired Immune Deciency Syndrome 2009, 52(2):280-289.
9. Carter S. AIDs doesn't kill its Customer: Understanding Barriers to Access and Adherence to HIV treatment among Young People Living in Peri-Urban Uganda. A thesis for master of Health Care and Epidemiology, University of British Columbia 2009, Available at Accessed September 2010., https://circle.ubc.ca/handle/2429/12709
10. Wolbers M, Bucher HC, Furrer H, et al. Delayed Diagnosis of HIV Infection and Late Initiation 0f Antiretroviral Therapy in the Swiss HIV Cohort Study. HIV Medicine 2008, 9:397-405. 10.1111/j.1468-1293.2008.00566.x, 18410354.
11. Thanawuth N, Chongsuvivatwong V. Late HIV diagnosis and delay in CD4 count measurement among HIV-infected patients in Southern Thailand. AIDS Care 2008, 20(1):43-50. 10.1080/09540120701439303, 18278614.
12. Bartlett JA, Hornberger J, Shewade A, Bhor M, Rajagopalan R. Obstacles and Proposed Solutions to Effective Antiretroviral Therapy in Resource-Limited Settings. J Int Assoc Physicians AIDS Care (Chic) 2009, 8(4):253-68. 10.1177/1545109709337745, 19721103.
13. Chakrapani V, Shanmugam M, Michael S, et al. Barriers to Free Antiretroviral Treatment Access for Female Sex Workers in Chennai, India. AIDS Patient Care and STDs 2009, 973-980. 10.1089/apc.2009.0035, 2832653, 19821725.
14. Marcus U, Michalik C, Brockmeyer NH, et al. Late and Early Presenters in the German KompNet Cohort - a comparison of socio-demographic variables. , http://www.kompetenznetz-hiv.de/media/Poster-SOEDAK2009-LatePresenters.pdf
15. Posse M, Baltussen R. Barriers to Access to Antiretroviral Treatment in Mozambique, as Perceived by Patients and Health Workers in Urban and Rural Settings. AIDS patient care and STDs 2009, 23(10):867-75.
16. Fox M, Mazimba A, Seidenberg P, et al. Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ART. Journal of the International AIDS Society 2010, 13:8. 10.1186/1758-2652-13-8, 2847987, 20205930.
17. Bailey Reed J, Hanson D, McNaghten AD, et al. HIV Testing Factors Associated with Delayed Entry into HIV Medical Care HIV-Infected Persons from Eighteen States, United States, 2000-2004. AIDS patient care and STDs 2009, 23(9):765-73. 10.1089/apc.2008.0213, 19694550.
18. Louis C, Ivers LC, Smith Fawz MC, et al. Late presentation for HIV care in central Haiti: factors limiting access to care. AIDS Care 2007, 19(4):487-491. 10.1080/09540120701203246, 17453588.
19. Marcellin F, Abe C, Loubiere S, et al. Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS 2009, 23:1015-1019. 10.1097/QAD.0b013e32832a5996, 19339871.
20. Bonjour MA, Montagne M, Zambrano M, et al. Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: A case-case comparison. AIDS Research and Therapy 2008, 5:6. 10.1186/1742-6405-5-6, 2377254, 18416849.
21. Delpierre C, Dray-Spira R, Cuzin L, et al. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS 2007, 18(5):312-317. 10.1258/095646207780749709, 2486458, 17524190.